- 17 May 2013
Scientists develop new methods to produce embryonic stem cells Researchers in the USA have developed a new method to generate embryonic stem cells which may bring stem cell treatments a step closer.
- 11 May 2013
New registry for people with FSH muscular dystrophy launched A new patient registry for individuals with facioscapulohumeral (FSH) muscular dystrophy, funded by the Muscular Dystrophy Campaign has been launched today.
- 1 May 2013
Sarepta Therapeutics update Over the past few weeks Sarepta Therapeutics have announced updates about their clinical trials and pre-clinical research into exon skipping technology.
- 16 April 2013
Laboratory visit for our supporters We visited Prof. Matthew Wood's laboratory in Oxford to get an exclusive, behind the scenes update on their exciting research. We were joined on the visit by supporters from around the country who are funding Prof. Wood's research.
- 12 April 2013
GSK announces results of exon skipping trial At a conference in the USA, Glaxosmithkline has announced preliminary results from a phase 2 clinical trial of exon skipping technology in boys with Duchenne muscular dystrophy.
- 8 April 2013
An update on our annual grant round An update on the progress of this year's grant round, which started in October 2012.
- 27 March 2013
Behind the scenes laboratory visit for families Families affected by Duchenne muscular dystrophy saw firsthand the progress Professor George Dickson and his team are making in pioneering work into treatments for Duchenne muscular dystrophy, as they toured their laboratories.
- 23 March 2013
Report from the UK Neuromuscular Translational Research Conference Nearly 200 people gathered in Oxford for the sixth annual UK Neuromuscular Translational Research Conference. with a busy program of talks and posters presented by international experts in the field of neuromuscular diseases.
- 20 March 2013
Public back mitochondrial transfer IVF The Human Fertilisation and Embryology Authority has announced the findings of its consultation with the public on mitochondrial transfer IVF. It found that people in the UK are broadly in support of the further development of this procedure.
- 8 March 2013
Side effects reported in GSK exon skipping trials GSK has announced that several participants in exon skipping clinical trials have experienced side effects. However, we remain confident that the safety of boys in the trials is a priority and that all boys are being carefully monitored.